What changes has the US made to its child immunization schedule?

Several childhood vaccines, including those for rotavirus, influenza, meningococcal disease, and hepatitis A, have been moved to a 'shared clinical decision-making' category, requiring consultation with healthcare providers.

How does Merck view the changes to the US child vaccine schedule?

Merck believes any changes to the immunization schedule should rely on comprehensive data and expert guidance to ensure children remain protected against preventable diseases.

What are the potential impacts of the US vaccine schedule shift?

Public health specialists worry about reduced vaccination rates, potentially leading to more preventable hospitalizations and deaths, while analysts predict significant revenue impact for Merck.

Home / Health / Merck Defends Child Vaccine Schedule Amid Policy Shift

Merck Defends Child Vaccine Schedule Amid Policy Shift

9 Jan

•

Summary

Merck urges comprehensive data for immunization schedule changes.
Several childhood vaccines moved to shared decision-making category.
Potential $2 billion annual revenue impact for Merck estimated.

Merck Defends Child Vaccine Schedule Amid Policy Shift

Merck emphasized that any modifications to the U.S. child and adolescent immunization schedule must be based on thorough data and the advice of vaccine experts. This stance comes after federal health officials recently shifted vaccines for rotavirus, influenza, meningococcal disease, and hepatitis A into a "shared clinical decision-making" category, advising parents to consult healthcare providers. Public health experts fear this change could lead to increased preventable hospitalizations and deaths due to lower vaccination uptake.

Company representatives stated that clear, evidence-based recommendations are crucial for informed decisions and ensuring children receive reliable protection. They highlighted the serious consequences of declining vaccination rates, especially with recent outbreaks. Merck affirmed its commitment to an immunization framework grounded in rigorous science and ongoing safety monitoring, vowing to collaborate with public health partners on policies safeguarding children and adolescents.